These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30797147)

  • 21. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal 5-HT1A, not the 5-HT1B or 5-HT3 receptors, mediates descending serotonergic inhibition for late-phase mechanical allodynia of carrageenan-induced peripheral inflammation.
    Kim JM; Jeong SW; Yang J; Lee SH; Kim WM; Jeong S; Bae HB; Yoon MH; Choi JI
    Neurosci Lett; 2015 Jul; 600():91-7. PubMed ID: 26037417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
    Hsu ES
    Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
    Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
    Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis.
    Tang DH; Malone DC
    Clin Ther; 2012 Feb; 34(2):282-94. PubMed ID: 22296947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
    Aminian A; Noorbakhsh F; Ghazi-Khansari M; Kafami L; Javadi S; Hassanzadeh G; Rahimian R; Dehpour AR; Mehr SE
    Neuroscience; 2013 Sep; 248():299-306. PubMed ID: 23774631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT
    Kovac AL
    Drugs; 2016 Dec; 76(18):1719-1735. PubMed ID: 27988869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
    Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
    Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems.
    Chen FC; Zhu J; Li B; Yuan FJ; Wang LH
    Drug Des Devel Ther; 2016; 10():1869-75. PubMed ID: 27350741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects.
    Stathis M; Pietra C; Rojas C; Slusher BS
    Eur J Pharmacol; 2012 Aug; 689(1-3):25-30. PubMed ID: 22683863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT3 receptors antagonists reduce serotonin-induced scratching in mice.
    Ostadhadi S; Kordjazy N; Haj-Mirzaian A; Mansouri P; Dehpour AR
    Fundam Clin Pharmacol; 2015 Jun; 29(3):310-5. PubMed ID: 25711853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of 5-HT₃ receptor antagonists on peripheral and central diseases.
    Fakhfouri G; Rahimian R; Ghia JE; Khan WI; Dehpour AR
    Drug Discov Today; 2012 Jul; 17(13-14):741-7. PubMed ID: 22390946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists.
    Fakhfouri G; Mousavizadeh K; Mehr SE; Dehpour AR; Zirak MR; Ghia JE; Rahimian R
    Mol Neurobiol; 2015 Dec; 52(3):1670-1679. PubMed ID: 25377794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT
    Fakhfouri G; Rahimian R; Dyhrfjeld-Johnsen J; Zirak MR; Beaulieu JM
    Pharmacol Rev; 2019 Jul; 71(3):383-412. PubMed ID: 31243157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
    Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
    Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT(3) receptors: role in disease and target of drugs.
    Walstab J; Rappold G; Niesler B
    Pharmacol Ther; 2010 Oct; 128(1):146-69. PubMed ID: 20621123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice.
    Zirak MR; Rahimian R; Ghazi-Khansari M; Abbasi A; Razmi A; Mehr SE; Mousavizadeh K; Dehpour AR
    Eur J Pharmacol; 2014 Sep; 738():222-9. PubMed ID: 24905858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 5-HT
    Skovgård K; Agerskov C; Kohlmeier KA; Herrik KF
    Neuropharmacology; 2018 Dec; 143():130-142. PubMed ID: 30243914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.